These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Modification of nasal membrane potential difference with inhaled amiloride and loperamide in the cystic fibrosis (CF) mouse. Ghosal S, Taylor CJ, McGaw J. Thorax; 1996 Dec; 51(12):1229-32. PubMed ID: 8994520 [Abstract] [Full Text] [Related]
23. Sodium channel blockers and uridine triphosphate: effects on nasal potential difference in cystic fibrosis mice. Ghosal S, Taylor CJ, Colledge WH, Ratcliff R, Evans MJ. Eur Respir J; 2000 Jan; 15(1):146-50. PubMed ID: 10678637 [Abstract] [Full Text] [Related]
24. The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis. Rodgers HC, Knox AJ. Eur Respir J; 1999 Sep; 14(3):693-6. PubMed ID: 10543294 [Abstract] [Full Text] [Related]
25. Cystic fibrosis and non-cystic-fibrosis human nasal epithelium show analogous Na+ absorption and reversible block by phenamil. Blank U, Rückes C, Clauss W, Hofmann T, Lindemann H, Münker G, Weber W. Pflugers Arch; 1997 May; 434(1):19-24. PubMed ID: 9094252 [Abstract] [Full Text] [Related]
26. Aldosterone metabolism and transepithelial potential difference in normal and cystic fibrosis subjects. Knowles MR, Gatzy JT, Boucher RC. Pediatr Res; 1985 Jul; 19(7):676-9. PubMed ID: 4022674 [Abstract] [Full Text] [Related]
27. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening. Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A. BMC Pediatr; 2006 Oct 03; 6():25. PubMed ID: 17018149 [Abstract] [Full Text] [Related]
28. The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis. Davies MG, Geddes DM, Alton EW. Am J Respir Crit Care Med; 2005 Apr 01; 171(7):760-3. PubMed ID: 15618459 [Abstract] [Full Text] [Related]
30. Nasal potential difference in congenital bilateral absence of the vas deferens. Pradal U, Castellani C, Delmarco A, Mastella G. Am J Respir Crit Care Med; 1998 Sep 01; 158(3):896-901. PubMed ID: 9731023 [Abstract] [Full Text] [Related]
31. Role of K(V)LQT1 in cyclic adenosine monophosphate-mediated Cl(-) secretion in human airway epithelia. Mall M, Wissner A, Schreiber R, Kuehr J, Seydewitz HH, Brandis M, Greger R, Kunzelmann K. Am J Respir Cell Mol Biol; 2000 Sep 01; 23(3):283-9. PubMed ID: 10970817 [Abstract] [Full Text] [Related]
32. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. Knowles MR, Clarke LL, Boucher RC. N Engl J Med; 1991 Aug 22; 325(8):533-8. PubMed ID: 1857389 [Abstract] [Full Text] [Related]
33. X-ray micro-analysis of cultured respiratory epithelial cells from patients with cystic fibrosis. Sagström S, Roomans GM, Wroblewski R, Keulemans JL, Hoogeveen AT, Bijman J. Acta Physiol Scand; 1992 Oct 22; 146(2):213-20. PubMed ID: 1332423 [Abstract] [Full Text] [Related]
34. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. App EM, King M, Helfesrieder R, Köhler D, Matthys H. Am Rev Respir Dis; 1990 Mar 22; 141(3):605-12. PubMed ID: 2310093 [Abstract] [Full Text] [Related]
35. Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis. Wheatley CM, Baker SE, Morgan MA, Martinez MG, Liu B, Rowe SM, Morgan WJ, Wong EC, Karpen SR, Snyder EM. Respir Med; 2015 Aug 22; 109(8):1001-11. PubMed ID: 26077038 [Abstract] [Full Text] [Related]